Clinical Trial

Prospective Registry of Acute Coronary Syndromes in Ferrara

Study acronym: ARYOSTO
Recruiting
View on ClinicalTrials.gov →
Summary
The ARYOSTO has been designed to describe the clinical epidemiology and the current management of acute coronary syndromes (ACS) in the area of Ferrara. Especially, the Authors will evaluate the medical and interventional management of ACS patients admitted to hospitals in the area of Ferrara and receiving coronary artery angiography and percutaneous coronary intervention (PCI) in the hub center of Ferrara (Azienda Ospedaliera Universitaria di Ferrara, Cona (FE), Italy)
Protocol Amendment History 10 amendments
This ClinicalTrials.gov record has been amended 10 times since 2015-05-05; most recent amendment 2023-11-12.
Trial Details
NCT Number NCT02438085
Lead Sponsor University Hospital of Ferrara
Conditions Acute Coronary Syndromes
Enrollment 10,000 participants
Start Date 2014-06
Primary Completion 2028-11-30 (estimated)
Study Completion 2032-11-30 (estimated)
Updated on ClinicalTrials.gov 2023-11-14